Phio Pharmaceuticals Corp. Annual Nonoperating Income (Expense) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Phio Pharmaceuticals Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • Phio Pharmaceuticals Corp. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $68K.
  • Phio Pharmaceuticals Corp. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $123K.
  • Phio Pharmaceuticals Corp. annual Nonoperating Income (Expense) for 2023 was -$2K, a 88.9% increase from 2022.
  • Phio Pharmaceuticals Corp. annual Nonoperating Income (Expense) for 2022 was -$18K, a 108% decline from 2021.
  • Phio Pharmaceuticals Corp. annual Nonoperating Income (Expense) for 2021 was $224K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2K +$16K +88.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$18K -$242K -108% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $224K +$225K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$1K -$80K -101% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $79K +$75K +1875% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $4K +$15K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 -$11K -$32K -152% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-27
2016 $21K +$7K +50% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-26
2015 $14K -$12K -46.2% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 $26K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.